Anixa Biosciences (ANIX) Change in Cash (2010 - 2025)
Anixa Biosciences' (ANIX) quarterly Change in Cash came in at -$251000.0 in Q4 2025, down 645.65% YoY from $46000.0 in Q4 2024, and up 39.52% on a QoQ basis from -$415000.0 in Q3 2025.
Anixa Biosciences (ANIX) Change in Cash (2010 - 2025) Analysis & Trends
Anixa Biosciences (ANIX) has 16 years of Change in Cash data on file, last reported at -$251000.0 in Q4 2025.
- Quarterly Change in Cash fell 645.65% year-over-year to -$251000.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was -$27000.0 (down 107.58% YoY) and the FY2025 annual result came in at -$27000.0, down 107.58% from the prior year.
- Change in Cash improved to -$251000.0 in Q4 2025, from -$415000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $15.7 million in Q2 2021 to a low of -$11.9 million in Q4 2022.
- A 5-year average of -$258650.0 and a median of -$234500.0 in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash slumped 724.03% — and 2025, when it jumped 28666.67%.
- Tracing ANIX's Change in Cash over 5 years: stood at $1.9 million in 2021, then tumbled by 724.03% to -$11.9 million in 2022, then soared by 80.81% to -$2.3 million in 2023, then surged by 102.01% to $46000.0 in 2024, then slumped by 645.65% to -$251000.0 in 2025.
- The last three Change in Cash figures came in at -$251000.0 (Q4 2025), -$415000.0 (Q3 2025), and $857000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -251,000.00 |
| Jul 31, 2025 | -415,000.00 |
| Apr 30, 2025 | 857,000.00 |
| Jan 31, 2025 | -218,000.00 |
| Oct 31, 2024 | 46,000.00 |
| Jul 31, 2024 | 230,000.00 |
| Apr 30, 2024 | -3,000.00 |
| Jan 31, 2024 | 83,000.00 |
| Oct 31, 2023 | -2.28 Mn |
| Jul 31, 2023 | -2.42 Mn |
| Apr 30, 2023 | -4.17 Mn |
| Jan 31, 2023 | -2.57 Mn |
| Oct 31, 2022 | -11.89 Mn |
| Jul 31, 2022 | -3.48 Mn |
| Apr 30, 2022 | -2.05 Mn |
| Jan 31, 2022 | 653,000.00 |
| Oct 31, 2021 | 1.91 Mn |
| Jul 31, 2021 | -481,000.00 |
| Apr 30, 2021 | 15.72 Mn |
| Jan 31, 2021 | 5.57 Mn |